| ActiBiso™ CBD 99 | Bisor Corporation |
|
ActiBiso™ CBD 99 has the function of promoting natural healing and anti-inflammation. It can promote skin hydration and can be used to improve skin inflammatory symptoms such as acne, eczema, and psoriasis.
Compliance Highlights Available
|
Request Sample |
| Cytobiol™ Iris A2 | Gattefossé |
|
Cytobiol™ Iris A2 is an active ingredient for problem skin. A synergistic blend of Iris, Zinc, and Vitamin A, Cytobiol™ Iris A2 is designed to treat problem skin. On acne prone or oily skin, it reduces sebum production to fight shine and kills bacteria ...view more
Cytobiol™ Iris A2 is an active ingredient for problem skin. A synergistic blend of Iris, Zinc, and Vitamin A, Cytobiol™ Iris A2 is designed to treat problem skin. On acne prone or oily skin, it reduces sebum production to fight shine and kills bacteria to prevent pimples and breakouts. It is also an effective anti-aging ingredient as it has been proven to shrink pore size. Substantiated in vivo. Preservative free. view less
Compliance Highlights Available
|
Request Sample |
| GATULINE® SPOT-LIGHT | Gattefossé |
|
Gatuline® Spot-Light is a safe and natural solution for a brighter skin complexion with less visible age spots. Targeting dermal and epidermal causes of hyperpigmentation, this new active brings strong and visible clinical efficacy (tested on Asian skins...view more
Gatuline® Spot-Light is a safe and natural solution for a brighter skin complexion with less visible age spots. Targeting dermal and epidermal causes of hyperpigmentation, this new active brings strong and visible clinical efficacy (tested on Asian skins). Gatuline® Spot-Light reduces the visibility, the number and the appearance of age spots while lightening the skin tone. This active will be suitable for creams or serums with brightening or illuminating properties, for the treatements of dark spots in hand care, body care or facial care . view less
Compliance Highlights Available
|
Request Sample |
| Traxmic™ | Bisor Corporation |
|
Traxmic™ is a synthetic derivative of the amino acid lysine with antifibrinolytic activity. With a strong affinity for the five lysine-binding sites of plasminogen, Traxmic™ competitively inhibits the activation of plasminogen to plasmin, resulting in inh...view more
Traxmic™ is a synthetic derivative of the amino acid lysine with antifibrinolytic activity. With a strong affinity for the five lysine-binding sites of plasminogen, Traxmic™ competitively inhibits the activation of plasminogen to plasmin, resulting in inhibition of fibrinolysis; at higher concentrations, this agent noncompetitively inhibits plasmin. This agent has a longer half-life, is approximately ten times more potent, and is less toxic than aminocaproic acid, which possesses similar mechanisms of action. view less
Compliance Highlights Available
|
Request Sample |
